OrganiGram Holdings Inc.

OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. It focuses on producing cannabis for patients and adult recreational consumers. The firm's brands include Adult Recreational and Medical. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

OrganiGram Holdings, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. Its brands include Edison, Big Bag O’ Buds, SHRED, Monjour, and Trailblazer. The company was founded on July 5, 2010 and is headquartered in Toronto, Canada.

Investors need to pay close attention to OrganiGram (OGI) stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in OrganiGram (OGI) Stock?

Aphria

Canopy Growth

GW Pharmaceuticals

Jazz Pharmaceuticals

Tilray Brands

Cannabis stocks seem poised to gain on hopes of removal of the federal ban on cannabis products under the new administration.

Cannabis Stocks Rise on Hopes of Federal Legalization in US

Investors in the Canadian pot growers are seeing potential outside the Great White North.

Why Tilray, Aphria, and OrganiGram Stocks Are All Soaring Today

Aurora Cannabis

HEXO Corp

The U.S. Cold War against cannabis is rapidly thawing.

Why a Slew of Marijuana Stocks Blasted Higher Today

OrganiGram (OGI) stock is heading higher on Monday with heavy trading despite a lack of news concerning the marijuana company. The post OGI Stock: 7 Things to Know About Cannabis Play OrganiGram as Shares Blaze Higher appeared first on InvestorPlace.

OGI Stock: 7 Things to Know About Cannabis Play OrganiGram as Shares Blaze Higher

GameStop

Pinterest

Block

Teladoc

Trupanion

The Reddit-rally stocks can't hold a candle to the potential of these five growth stocks over the next decade.

Forget AMC and GameStop: These 5 Stocks Are Future 10-Baggers

Marijuana stocks are soaring higher on a string of Democratic electoral wins. But not every company in this troubled sector is a winner.

3 Marijuana Stocks With High Hopes for the Future

SNDL Inc.

These undervalued marijuana stocks have the potential to surge in the next few quarters as growth accelerates and cash burn declines. The post 4 Undervalued Marijuana Stocks to Buy appeared first on InvestorPlace.

4 Undervalued Marijuana Stocks to Buy

Some pot stocks are jumping double digits after recent comments from Democratic lawmakers.

Why Tilray, Aphria, OrganiGram, and Aurora Cannabis Rose Today

A top executive at the company is heading for the exit.

Why OrganiGram Holdings Lagged Behind Other Marijuana Stocks on Tuesday

MONCTON, New Brunswick--(BUSINESS WIRE)---- $OGI--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announces Matt Rogers, Senior Vice President, Operations, will be leaving Organigram at the end of May 2021 to pursue other interests. Organigram would like to thank Matt for his efforts helping Organigram grow from a licensed producer of medical cannabis to one of the country's leading producers of both medical and adult use recreational products. One of Organigram's earli

Organigram Announces Executive Changes

Amazon

Zoom Video

Millennial investors are right to pile into these high-growth businesses.

3 Superb Robinhood Stocks That Can Double Your Money

Salesforce

Alphabet

Young investors have every right to be excited about these fast-growing companies.

4 Robinhood Growth Stocks That'll Make You Richer in 2021

Amyris

Cronos Group

GrowGeneration Corp

Village Farms International

These are the marijuana stocks on the NASDAQ with the best value, fastest growth, and the most momentum for February.

Top Marijuana Stocks on the NASDAQ for February 2021

Curaleaf Holdings, Inc.

As the world begins to accept the medical and recreational use of cannabis and its benefits, the cannabis industry begins to explode.

Top Marijuana Stocks to Watch

Exelixis

Fastly

Intuitive Surgical

Visa

Buying and holding innovative businesses is a time-tested way to build wealth.

Who's Ready to Get Rich? 5 Moneymaker Stocks to Buy Now

Arena Pharmaceuticals

Molson Coors Brewing

Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks over the past week, and look ahead to how the cannabis industry will develop in the new year.

9 Cannabis Stocks Heating Up Headlines This Week

These growers are facing mounting losses year after year.

3 Pot Stocks to Flat-Out Avoid in 2021

The company's latest set of quarterly results isn't giving investors much of a high.

Why OrganiGram Holdings Dove on Tuesday

OrganiGram Holdings Inc. (OGI) CEO Gregory Engel on Q1 2021 Results - Earnings Call Transcript

Organigram Holdings Inc. (OGI) delivered earnings and revenue surprises of -300.00% and -8.34%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?

Organigram Holdings Inc. (OGI) Reports Q1 Loss, Misses Revenue Estimates

The U.S.-listed shares of OrganiGram Holdings Inc. dropped 2.3% in premarket trading, as the Canada-based cannabis company reported a much wider fiscal first-quarter net loss and net revenue that fell more than forecast, while adult-use recreational cannabis revenue jumped. The net loss for the quarter to Nov. 30 increased to C$34.3 million ($26.9 million) from about C$863,000 in the same period a year ago.

OrganiGram stock drops after cannabis company reports wider loss, revenue miss

MONCTON, New Brunswick--(BUSINESS WIRE)---- $OGI--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended November 30, 2020 (“Q1 Fiscal 2021” or “Q1 2021”). Select Key Financial Metrics (in $000s) unless otherwise indicated Q1 2021 Q1 2020 % Change Gross revenue 25,280 28,448 -11% Excise taxes (5,949) (3,295) 81% Net revenue 19,331 25,153

Organigram Reports First Quarter Fiscal 2021 Results

It's still not too late to invest in this rapidly growing industry.

These 2 Pot Stocks Cost Less Than $3. Can They Double Your Money?

MONCTON, New Brunswick--(BUSINESS WIRE)---- $OGI--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the appointment of Marni Wieshofer, to the Company's Board of Directors. Ms. Wieshofer is Organigram's first U.S. domiciled director and will assume her board position effective January 12, 2021. Ms. Wieshofer has more than thirty years of diverse experience, including Bo

Organigram Appoints Marni Wieshofer to the Board of Directors

News for OrganiGram Holdings Inc. Stock (OGI)